Streptokinase, β-hemolytic streptococcus (Lancefield Group C)

• UNSPSC Description:

  Streptokinase, β-hemolytic streptococcus (Lancefield Group C) is a bacteria-derived protein and a plasminogen activator. Streptokinase is widely used for the research of the blood-clotting disorders. Streptokinase improves reperfusion blood flow after coronary artery occlusion[1][2].

• Target Antigen:

  Bacterial

• Type:

  Enzyme

• Related Pathways:

  Anti-infection

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/streptokinase-β-hemolytic-streptococcus-lancefield-group-c.html

• Solubility:

  10 mM in DMSO

• Smiles:

  [Streptokinase, b-hemolytic streptococcus (Lancefield Group C)]

• References & Citations:

  [1]Vaughan DE, et al. Streptokinase-induced platelet aggregation. Prevalence and mechanism. Circulation. 1991;84(1):84-91. |[2]Mickelson JK, et al. Streptokinase improves reperfusion blood flow after coronary artery occlusion. Int J Cardiol. 1989;23(3):373-384.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Store at -20°C for 2 years

• Clinical Information:

  No Development Reported

• CAS Number:

  9002-01-1